Clinical Trial Update: Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD Alone [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing trifluorothymidine (FTD) when administered as part of TAS-102 versus FTD alone in patients with advanced solid tumors; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TAS-102 (trifluridine/tipiracil)
• Trifluridine (trifluridine)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED